Association of Platelet to Lymphocyte Ratio with Inflammation and Severity of Coronary Atherosclerosis in Patients with Stable Coronary Artery Disease

Angiology

Volumn 67, Issue 1, 2016, Pages 89-95

  Akboga, Mehmet Kadri ^a   Canpolat, Ugur ^a   Yayla, Cagri ^a   Ozcan, Firat ^a   Ozeke, Ozcan ^a   Topaloglu, Serkan ^a   Aras, Dursun ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

C reactive protein; coronary atherosclerosis; Gensini score; inflammation; platelet to lymphocyte ratio

Indexed keywords

ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADULT; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GENSINI SCORE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PLATELET LYMPHOCYTE RATIO; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; STABLE CORONARY ARTERY DISEASE; THROMBOCYTE COUNT; ATHEROSCLEROSIS; BLOOD; BLOOD CELL COUNT; COMPLICATION; CORONARY ANGIOGRAPHY; LYMPHOCYTE; METABOLISM; MIDDLE AGED; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; THROMBOCYTE;

ATHEROSCLEROSIS; BIOMARKERS; BLOOD CELL COUNT; BLOOD PLATELETS; C-REACTIVE PROTEIN; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFLAMMATION; LYMPHOCYTES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84949604434     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319715583186     Document Type: Article

References (36)

1. Libby P,. Inflammation in atherosclerosis. Nature. 2002; 420 (6917): 868-874.
2. Drakopoulou M, Toutouzas K, Stefanadi E, Tsiamis E, Tousoulis D, Stefanadis C,. Association of inflammatory markers with angiographic severity and extent of coronary artery disease. Atherosclerosis. 2009; 206 (2): 335-339.
3. Turfan M, Duran M, Poyraz F, et al. Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. Coron Artery Dis. 2013; 24 (1): 29-32.
4. Ly HQ, Kirtane AJ, Murphy SA, et al. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol. 2006; 98 (1): 1-5.
5. Iijima R, Ndrepepa G, Mehilli J, et al. Relationship between platelet count and 30 day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials. Thromb Haemost. 2007; 98 (4): 852-857.
6. Nikolsky E, Grines CL, Cox DA, et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial). Am J Cardiol. 2007; 99 (8): 1055-1061.
7. Ommen SR, Gibbons RJ, Hodge DO, Thomson SP,. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol. 1997; 79 (6): 812-814.
8. Zouridakis EG, Garcia-Moll X, Kaski JC,. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol. 2000; 86 (4): 449-451.
9. Proctor MJ, Morrison DS, Talwar D, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow inflammation outcome study. Eur J Cancer. 2011; 47 (17): 2633-2641.
10. Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O,. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. J Thromb Thrombolysis. 2015; 39 (2): 179-185.
11. Gary T, Pichler M, Belaj K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013; 8 (7): e67688.
12. Azab B, Shah N, Akerman M, McGinn JT Jr,. Value of platelet/ lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34 (3): 326-334.
13. Ugur M, Gul M, Bozbay M, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis. 2014; 25 (8): 806-811.
14. Yüksel M, Ylldlz A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anadolu Kardiyol Derg. 2014. doi:10.5152/akd.2014.5565.
15. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012; 60 (24): e44-e164.
16. Gensini GG,. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983; 51 (3): 606.
17. Akboga MK, Canpolat U, Sahinarslan A, et al. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation. Atherosclerosis. 2015; 240 (1): 110-114.
18. Hansson GK,. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352 (16): 1685-1695.
19. Lindemann S, Kramer B, Seizer P, Gawaz M,. Platelets, inflammation and atherosclerosis. J Thromb Haemost. 2007; 5 (suppl 1): 203-211.
20. Gawaz M, Langer H, May AE,. Platelets in inflammation and atherogenesis. J Clin Invest. 2005; 115 (12): 3378-3384.
21. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF,. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991; 84 (2): 613-617.
22. Horne BD, Anderson JL, John JM, et al.Intermountain Heart Collaborative Study Group. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005; 45 (10): 1638-1643.
23. Thomson SP, McMahon LJ, Nugent CA,. Endogenous cortisol: a regulator of the number of lymphocytes in peripheral blood. Clin Immunol Immunopathol. 1980; 17 (4): 506-514.
24. Akboga MK, Canpolat U, Balci K, et al. Increased platelet to lymphocyte ratio is related to slow coronary flow. Angiology. 2015. doi: 10.1177/0003319715574625.
25. Yayla C, Akboga MK, Canpolat U, et al. Platelet to lymphocyte ratio can be a predictor of infarct-related artery patency in patients with ST-segment elevation myocardial infarction. Angiology. 2015. doi: 10.1177/0003319715573658.
26. Sunbul M, Gerin F, Durmus E, et al. Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension. Clin Exp Hypertens. 2014; 36 (4): 217-221.
27. Munk PS, Breland UM, Aukrust P, Skadberg O, Ueland T, Larsen AI,. Inflammatory response to percutaneous coronary intervention in stable coronary artery disease. J Thromb Thrombolysis. 2011; 31 (1): 92-98.
28. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999; 99 (2): 237-242.
29. Kuller LH, Tracy RP, Shaten J, Meilahn EN,. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996; 144 (6): 537-547.
30. Ray KK, Nazer B, Cairns R, Michael Gibson C, Cannon CP,. Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes. J Thromb Thrombolysis. 2010; 30 (1): 10-13.
31. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350 (14): 1387-1397.
32. Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999; 106 (5): 506-512.
33. Morrow DA, de Lemos JA, Sabatine MS, et al. Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial. Circulation. 2006; 114 (4): 281-288.
34. Cicek G, Aclkgoz SK, Bozbay M, et al. Neutrophil-Lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Angiology. 2014. doi: 10.1177/0003319714535970.
35. Balta S, Demirkol S, Arslan Z, Celik T, Unlu M, Iyisoy A,. Retinal vessel abnormalities and coronary artery diseases. Perfusion. 2013; 28 (5): 465.
36. Balta S, Ozturk C,. The platelet-lymphocyte ratio: A simple, inexpensive and rapid prognostic marker for cardiovascular events. Platelets. 2014; 30: 1-2.